SCHEMBL166441

SCHEMBL166441

COC(=O)c1cccc(C(=O)O)c1N(C)S(C)(=O)=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.61
L3MBTL1 Q9Y468 3/20 0.46
GAA P10253 3/20 0.45
NPSR1 Q6W5P4 1/20 0.45
POLB P06746 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA5A P35218 1/20 0.43
CA9 Q16790 1/20 0.43
KDM4E B2RXH2 2/20 0.41
MAPK1 P28482 1/20 0.41
TSHR P16473 4/20 0.41
LMNA P02545 3/20 0.41
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPT P10636 2/20 0.41
HTT P42858 1/20 0.41
CFTR P13569 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5186948 0.89 KMT2A (0.47) KMT2AL3MBTL1NPSR1KDM4EMAPK1
SCHEMBL28137440 0.82 TSHR (0.47) KMT2AL3MBTL1GAANPSR1POLB
SCHEMBL4752383 0.81 KMT2A (0.42) KMT2AL3MBTL1POLBKDM4ETSHR
SCHEMBL7322996 0.80 MMP9 (0.54) KMT2AGAANPSR1KDM4ELMNA
SCHEMBL27540668 0.78 ALB (0.47) KMT2AL3MBTL1TSHRALDH1A1MEN1
SCHEMBL647372 0.76 KMT2A (1.00) KMT2AL3MBTL1GAANPSR1POLB
SCHEMBL7554619 0.75 KMT2A (0.52) KMT2AL3MBTL1GAANPSR1POLB
SCHEMBL7550294 0.75 KMT2A (0.52) KMT2AL3MBTL1POLBCA1CA2
SCHEMBL27736140 0.75 TSHR (0.53) KMT2AL3MBTL1NPSR1POLBCA1
SCHEMBL2250340 0.72 ALB (0.44) KMT2AL3MBTL1GAAPOLBCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611441-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F.HOFFMANN-LA ROCHE AG (CH) 2013-07-10 EP disclosed
WO-2012028563-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2012-03-08 WO disclosed